Miriam O

Open Access Rheumatology: Research and Reviews Dovepress Long-term Safety and Efficacy of Biosimilar Infliximab among Patients with Inflammatory Arthritis Switched from Reference Product

T. Walsh, G. Mannion, R. Conway, 2022 .